Vanda Pharmaceuticals Inc (VNDA)
5.04
+0.02
(+0.40%)
USD |
NASDAQ |
May 10, 16:00
5.04
0.00 (0.00%)
After-Hours: 16:07
Vanda Pharmaceuticals Price: 5.04 for May 10, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 09, 2024 | 5.15 | 5.38 | 4.94 | 5.02 | 1.898M |
| May 08, 2024 | 5.52 | 5.64 | 5.305 | 5.36 | 2.041M |
| May 07, 2024 | 5.20 | 5.95 | 5.17 | 5.48 | 4.717M |
| May 06, 2024 | 5.00 | 5.032 | 4.79 | 4.84 | 1.288M |
| May 03, 2024 | 4.71 | 4.91 | 4.700 | 4.88 | 681346.0 |
| May 02, 2024 | 4.80 | 4.84 | 4.665 | 4.68 | 847705.0 |
| May 01, 2024 | 4.76 | 4.90 | 4.62 | 4.77 | 1.748M |
| Apr 30, 2024 | 4.78 | 4.815 | 4.710 | 4.76 | 692276.0 |
| Apr 29, 2024 | 4.68 | 4.850 | 4.662 | 4.82 | 821763.0 |
| Apr 26, 2024 | 4.50 | 4.625 | 4.45 | 4.62 | 821939.0 |
| Apr 25, 2024 | 4.55 | 4.57 | 4.43 | 4.48 | 923301.0 |
| Apr 24, 2024 | 4.63 | 4.67 | 4.551 | 4.56 | 1.459M |
| Apr 23, 2024 | 4.76 | 4.87 | 4.62 | 4.63 | 1.371M |
| Apr 22, 2024 | 5.10 | 5.12 | 4.785 | 4.80 | 2.115M |
| Apr 19, 2024 | 4.94 | 5.30 | 4.93 | 5.11 | 2.441M |
| Apr 18, 2024 | 5.16 | 5.245 | 4.89 | 4.97 | 3.860M |
| Apr 17, 2024 | 5.42 | 5.67 | 4.99 | 5.24 | 24.04M |
| Apr 16, 2024 | 4.02 | 4.08 | 3.985 | 4.05 | 790418.0 |
| Apr 15, 2024 | 4.12 | 4.16 | 4.01 | 4.06 | 787157.0 |
| Apr 12, 2024 | 4.27 | 4.30 | 4.08 | 4.12 | 762864.0 |
| Apr 11, 2024 | 4.30 | 4.32 | 4.18 | 4.28 | 766830.0 |
| Apr 10, 2024 | 4.30 | 4.37 | 4.14 | 4.28 | 1.159M |
| Apr 09, 2024 | 4.49 | 4.68 | 4.34 | 4.36 | 1.795M |
| Apr 08, 2024 | 4.83 | 4.83 | 4.49 | 4.51 | 1.690M |
| Apr 05, 2024 | 4.97 | 4.99 | 4.79 | 4.82 | 1.670M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.38
Minimum
Nov 09 2023
21.51
Maximum
Jun 30 2021
11.30
Average
11.24
Median
Mar 15 2022
Price Benchmarks
| ADMA Biologics Inc | 8.81 |
| INVO Bioscience Inc | 1.00 |
| Johnson & Johnson | 149.88 |
| Nektar Therapeutics | 1.76 |
| Invivyd Inc | 2.265 |
Price Related Metrics
| PE Ratio | 96.22 |
| PS Ratio | 1.506 |
| Price to Book Value | 0.5322 |
| Price to Free Cash Flow | 23.36 |
| Earnings Yield | 1.04% |
| Market Cap | 289.99M |
| Normalized PE Ratio | 96.22 |